Loteprednol Etabonate Ophthalmic Suspension, 0.5%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
Mumbai, Naples, April 25, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.
Lupin gets USFDA approval for suspension to treat allergic conjunctivitis financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.